George Plain
Internal Medicine · Rochester, NYNPI 1881629145
Payments from drug & device makers
Across 371 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- Pfizer$566
- Johnson & Johnson$328
- GSK$322
- Astellas Pharma US Inc$321
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,54698%
- Education$1152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 88 | $1,020 |
| AbbVie(2 entities) | 68 | $1,018 |
| Pfizer | 43 | $566 |
| Johnson & Johnson | 18 | $328 |
| GSK | 18 | $322 |
| Astellas Pharma US Inc | 17 | $321 |
| Lilly USA, LLC | 19 | $292 |
| Amgen | 12 | $217 |
| Boehringer Ingelheim | 9 | $170 |
| AstraZeneca | 10 | $158 |
| Merck | 11 | $158 |
| Abbott | 7 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $131 |
| Novartis | 6 | $104 |
| Amarin Pharma, Inc. | 4 | $85 |
| Sanofi-aventis U.S. LLC | 4 | $82 |
| Insulet Corporation | 3 | $72 |
| Bayer | 3 | $69 |
| Kowa Pharmaceuticals America, Inc. | 2 | $56 |
| Biohaven Pharmaceuticals, Inc. | 3 | $56 |
| Alkermes, Inc. | 3 | $55 |
| Ultragenyx Pharmaceutical Inc. | 3 | $47 |
| Jazz Pharmaceuticals Inc. | 2 | $42 |
| Exact Sciences | 2 | $41 |
| Smith+Nephew | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Biogen | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$5,661 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 90 | $1,996 |
| Rosuvastatin Calcium | 72 | $1,731 |
| Levothyroxine Sodium | 77 | $1,562 |
| Valsartan | 50 | $1,372 |
| Amlodipine Besylate | 72 | $659 |
| Omeprazole | 37 | $625 |
| Lisinopril | 52 | $621 |
| Pantoprazole Sodium | 22 | $473 |
| Carvedilol | 28 | $444 |
| Tamsulosin Hcl | 23 | $424 |
| Metoprolol Succinate | 27 | $378 |
| Metformin Hcl ErMetformin Hcl | 23 | $288 |
| Gabapentin | 18 | $265 |
| Donepezil Hcl | 18 | $228 |
| Allopurinol | 15 | $208 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rochester
- Patrick ReaganRochester$9.4M
- Angela BrancheRochester$7.9M
- Patrick ConnorsRochester$4M
- Richard DunneRochester$1.6M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.